. MHT is the most appropriate therapy for fracture prevention in early menopause. . The use of estrogen under age 60 in healthy women reduces CHD and all-cause mortality. . Estrogen and progestogen appear to be cardioprotective. . MHT initiated in midlife is associated with a reduced risk of Alzheimer's disease and dementia.
Meanwhile, the Revised Global Consensus Statement on Menopausal Hormone Therapy 4 agrees that MHT is effective in the prevention of bone loss and can be initiated in women under age of 60 in women at risk of fracture or osteoporosis, but takes a middle road regarding cardiovascular prevention, stating that standard dose estrogen MHT may decrease the risk of myocardial infarction and all cause mortality when started in women under age 60 or within 10 years of the menopause.
Whether or not HRT/MHT will ever be recommended for primary prevention of osteoporosis, cardiovascular disease or dementia in women who do not require treatment for vasomotor symptoms is still unclear, but the combined effect of all these guidelines is that women and healthcare professionals can be reassured that HRT/MHT is an effective option for control of menopausal symptoms with minimal risks.
Guidelines are only useful if the key messages are widely read, understood and applied by both healthcare professionals and women themselves. The NICE guideline published in November 2015 received much media attention, yet a recent Ipsos Mori survey of a nationally representative sample of 1200 women aged 45-65 across Great Britain carried out on behalf of the British Menopause Society, showed that only 3% of women had heard of the NICE guideline. Further, despite the publicity around publication encouraging women to access information and seek help for symptoms, one in two women in the survey who experienced symptoms had not consulted a healthcare professional. This is despite the fact that women reported several symptoms which were often worse than expected and had an impact on home life, work, social life and sex life.
It is clear that much work is required to spread the trusted, authoritative guidance to healthcare professionals outside specialist societies so that women can be given consistent information, and to women so that they can have truly informed discussions.
